Analysis of Motor Complication and Relative Factors in a Cohort of Chinese Patients with Parkinson’s Disease

Table 4

The results of motor fluctuations and dyskinesia in different clinical stages.

	Total (n = 166)	Motor fluctuations (n = 52)	χ^2	value	Dyskinesia (n = 25)	χ^2	value
Age of onset (n, %)			16.625	<0.001		9.101	0.011
≤50 years	29 (17.47)	18 (62.07)			9 (31.03)
51–70 years	107 (64.46)	29 (27.10)			15 (14.02)
≥70 years	30 (18.07)	5 (16.67)			1 (3.33)
Duration of diseases			40.806	<0.001		48.692	<0.001
<5 years	91 (54.82)	11 (12.09)			2 (2.20)
5–10 years	59 (35.54)	28 (47.46)			12 (20.34)
≥10 years	16 (9.64)	13 (81.25)			11 (68.75)
Duration of L-dopa treatment (n, %)			67.265	<0.001		46.087	<0.001
≤2 years	98 (59.04)	7 (7.12)			0 (0.00)
2–5 years	36 (21.69)	21 (58.33)			11 (30.56)
5–10 years	23 (13.86)	17 (73.91)			9 (39.13)
≥10 years	9 (5.41)	7 (77.78)			5 (55.56)
Modified Hoehn–Yahr stages (n, %)			29.030	<0.001		46.030	<0.001
1–1.5	51 (30.72)	6 (11.76)			0 (0.00)
2–2.5	76 (45.78)	21 (27.63)			6 (7.89)
3-4	39 (23.50)	25 (64.10)			19 (48.72)
Daily levodopa dosages (n, %)			17.012	<0.001		6.880	0.032
≤300 mg	49 (29.52)	6 (12.24)			4 (8.16)
300–600 mg	91 (54.82)	31 (34.07)			13 (14.29)
≥600 mg	26 (15.66)	15 (57.69)			8 (30.77)